The long term goal is to define crystallographically the molecular interactions of Cbl in tyrosine kinase signal transduction. Cb1 is the product of the c-cbl proto-oncogene, and is an important element of signaling pathways activated by many growth factor, cytokine, and immune-cell receptors. Cb1 directly binds and inhibits target tyrosine kinases. The proposed structural analysis of Cbl, alone and in complex with the T-cell tyrosine kinase ZAP-70, will reveal mechanisms of recognition and catalytic regulation that are of fundamental importance in tyrosine kinase signaling. Further, these studies will provide the structural foundations for development of novel immunomodulatory and anti-cancer drugs. The structure of an N-terminal fragment of Cbl (Cbl-N) that includes its transforming and phosphotyrosine-binding activities is described in the preliminary studies. Unexpectedly, this region of Cbl is found to include an EF-hand calcium binding domain, a divergent Src homology-2 (SH2) domain, and a four-helix bundle. Calcium fluxes are an essential element of T-cell activation, and Cbl may represent an important but previously unrecognized target of this signal. The structural arrangement of the three domains in Cbl-N suggests that they may cooperate in recognition of phosphoproteins, and that recognition may be regulated by binding of calcium to the EF-hand domain.
The specific aims of this proposal are 1) to test this hypothesis by direct biochemical and structural analysis, and by collaborative structure/function analysis of Cbl's function in T-cell activation and cellular transformation, 2) to determine the structure of Cbl in complex with phosphopeptides derived from target kinases. In Cbl in complex with full-length ZAP-70, in order to see directly how it binds and inhibits target kinases. In addition to the 2.2A resolution structure of Cbl-N, preliminary studies have yielded structure-grade crystals of Cbl-N in complex with a twelve residue ZAP-70 phosphopeptide. A larger fragment of Cbl including the RING-finger domain has been expressed and purified; characterization of this protein suggests that it is suitable for structural studies. Full length ZAP-70 has been expressed and purified using a Baculovirus system; crystallographic analysis of this protein in complex Cbl will synergize with parallel efforts to determine the structure of ZAP-70 bound to the zeta-chain of the T-cell receptor.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA080942-05
Application #
6633359
Study Section
Biophysical Chemistry Study Section (BBCB)
Program Officer
Knowlton, John R
Project Start
1999-09-01
Project End
2005-11-30
Budget Start
2003-07-01
Budget End
2005-11-30
Support Year
5
Fiscal Year
2003
Total Cost
$264,306
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Tu, Daqi; Zhu, Zehua; Zhou, Alicia Y et al. (2013) Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep 3:747-58
Smurnyy, Yegor; Toms, Angela V; Hickson, Gilles R et al. (2010) Binucleine 2, an isoform-specific inhibitor of Drosophila Aurora B kinase, provides insights into the mechanism of cytokinesis. ACS Chem Biol 5:1015-20
Eck, Michael J; Yun, Cai-Hong (2010) Structural and mechanistic underpinnings of the differential drug sensitivity of EGFR mutations in non-small cell lung cancer. Biochim Biophys Acta 1804:559-66
Zhou, Wenjun; Ercan, Dalia; Chen, Liang et al. (2009) Novel mutant-selective EGFR kinase inhibitors against EGFR T790M. Nature 462:1070-4
Lietha, Daniel; Eck, Michael J (2008) Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation. PLoS One 3:e3800
Swanson, Kenneth D; Tang, Yong; Ceccarelli, Derek F et al. (2008) The Skap-hom dimerization and PH domains comprise a 3'-phosphoinositide-gated molecular switch. Mol Cell 32:564-75
Yun, Cai-Hong; Mengwasser, Kristen E; Toms, Angela V et al. (2008) The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc Natl Acad Sci U S A 105:2070-5
Blair, Jimmy A; Rauh, Daniel; Kung, Charles et al. (2007) Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. Nat Chem Biol 3:229-38
Lietha, Daniel; Cai, Xinming; Ceccarelli, Derek F J et al. (2007) Structural basis for the autoinhibition of focal adhesion kinase. Cell 129:1177-87
Yun, Cai-Hong; Boggon, Titus J; Li, Yiqun et al. (2007) Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell 11:217-27

Showing the most recent 10 out of 13 publications